Background. Methods. Study Objectives. Methods - 2. Pilot Study

Size: px
Start display at page:

Download "Background. Methods. Study Objectives. Methods - 2. Pilot Study"

Transcription

1 Current Administration Practices and Preferred Formulations of s Medicines in Tanzania Background 8.1 million child deaths / year Lack of pediatric formulations for many medicines to treat common illnesses Dispensing adult dosage forms Inaccurate dosing Formulations can affect adherence Lisa V. Adams, MD, Dartmouth Medical School, USA Inadequate information exists about current practices and preferences, esp from resource-poor countries Study Objectives Assess current admin. practices by HCWs and parents/caregivers in Tanzania Determine formulation preferences by HCWs, parents/caregivers, and children Assess social significance of medicines in this context Methods National cross-sectional survey 200 Licensed HCWs 200 parents/caregivers (> age 18) 200 children (between ages 6-12) 10 regions of Tanzania, including Zanzibar Random sampling 1 rural and 1 urban district in each region Ethical review by WHO, Dartmouth, Muhimbili and National Institute of Med. Research, Tanzania Methods - 2 Pilot Study Survey Tools 3 surveys developed Peer reviewed Translation and back translation Supplemental free text questions (10%) 12 Interviewers Research methods and ethics training Worked in pairs Balanced gender, regional and disciplinary background Conducted March interviews Urban and peri-urban Dar es Salaam Results of pilot informed revision of survey tools and contributed to interviewer training Established Data QA procedures Concurrent permissions for full data collection obtained during this time

2 Results Interviews 206 children 202 parents/caregivers 202 HCWs Dates: 17 May 6 July 2010 Stratified by setting (urban vs. rural) and by education level (<primary school, primary school, >primary school) Parent/Caregivers Most in every subgroup preferred sweet tasting medicines Greater preference for sweet medicines among respondents with more than a primary school education (P=0.0001). A higher prevalence of no preference among those with less than a primary school education (P=0.0001) & HCWs Syrups preferred for newborns toddlers; pills to swallow preferred for primary school aged; preschool aged children in cross-over No differences when compared by setting or education level Overall, age group rather than setting or education level seemed to be the main driver for stated preferences.

3 Most recent illness reported by child Malaria/Fever: 50.6% Diarrhea/Stomach: 17.6% Cough/pneumonia/chest: 13.7% Most recent illness reported by parents/caregivers Malaria/Fever: 71.8% Diarrhea/Stomach: 20.8% Cough/flu/pneumonia/chest: 41.6% *Responses were not mutually exclusive. Stratified by setting (urban vs. rural) and age (6-8 vs. 9-12) Healthcare Workers Clear preference for sweet tasting medicines No differences in taste preferences by setting Though all groups preferred sweet tasting medicines, this preference statistically significant for children aged 6 to 8 When asked about formulation preferences: 62% (128/168) syrup; 14.6% (30/168) capsule/tablet/pill Healthcare Workers Discussion Study Participant Overview Even gender balance among HCWs and children; more female parents/caregivers Lower level HCWs see majority of children in Tanzania Illnesses reported consistent with known disease epidemiology Dosing medicines by HCWs Nearly all HCWs report using scales to determine weights of pediatric patients All urban and rural HCWs report basing medication dose on both weight and age for all (100%) infants

4 Discussion - 2 Discussion - 3 Administration Practices Crushed pills mixed with water most common method of admin. reported for recent illness Pills swallowed whole by older children Problems with palatability and vomiting Prescriptions for impossible fractions Current admin. practices of parent/caregivers did not differ by setting or level of education Potable water obtained when giving children medicines Bottled water in some cases similar usage rate across urban and rural areas and by education level Overall, age group is the main driver for medication formulation preferences expressed by parent/caregivers; did not vary by setting or education level. Strong preference for syrups for youngest age groups (newborns, infants and toddlers), pills to swallow for older children Benefits to packaging of medicines by age group, e.g., age group color-coded labels or packaging and/or age group color-coded administration instructions Discussion - 4 Overwhelming preference among all cohorts for sweet tasting medicines Lack of preference for chewable tablets by parent/caregivers may indicate unfamiliarity rather than a lack of desirability The reality Most children being given pills, crushed or whole Problems with dosing, palatability, and adherence Non-adherence linked to side-effects, bad taste and vomiting Exacerbated by breaking pills, leading to bitter taste Discussion - 5 HCWs prefer syrups for children regardless of setting GPs prefer syrups and chewable tabs compared to RNs Infrequent preference expressed for dispersible and chewable tabs Possible lack of familiarity of with these formulations Factors Influencing Prescribing Availability of meds main determinant of choice for HCWs (practical considerations vs. ideal preferences) Ease of administration and tolerability next most important determinants for HCWs (formulation issues) Conclusions There are many impediments to acceptable and accurate administration of medicines to children Current administration practices clearly suboptimal Associated with poor tolerability & the potential for under or over-dosing Parents/caretakers, children and HCWs in Tanzania have clear preferences for pediatric medication taste and formulations More similarities than differences between stratified subpopulations All expressed a strong preference for sweet tasting medicines, syrups for younger age groups Their responses should be used to inform the development, manufacturing, and marketing of pediatric medications for resource-limited setting Ensuring availability of medicines (and possibly reasonable cost) should remain an important goal of child medicines initiatives, along with child-friendly formulations for ease of administration Next Steps and Recommendations Future plans Preparing manuscripts for publication Qualitative data analysis social science literature Study being conducted in Ghana Lessons learned from Tanzania study informed survey revisions, study implementation, and data management Recommendations for Drug Manufacturers Results should be used to inform new formulation development Both biopharmaceutical issues and social acceptability crucial

5 Acknowledgements

Industry Perspective on Formulation and Packaging Considerations

Industry Perspective on Formulation and Packaging Considerations Industry Perspective on Formulation and Packaging Considerations Ron Ogilvie (Pfizer) EFPIA February 2012 1 Industry Perspective on Formulation and Packaging Considerations Provide an overview of formulation

More information

Fixed Dose Combination a Simplified Approach to Pediatric Antiretroviral Treatment

Fixed Dose Combination a Simplified Approach to Pediatric Antiretroviral Treatment Fixed Dose Combination a Simplified Approach to Pediatric Antiretroviral Treatment Dr. David Pugatch Clinton Foundation Phnom Penh, Cambodia February, 2007 Lecture Goals To introduce and define fixed dose

More information

Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children WHO Headquarters, Geneva, Switzerland

Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children WHO Headquarters, Geneva, Switzerland Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children WHO Headquarters, Geneva, Switzerland Comments of the Malta Chamber of Pharmacists 15 th February 2008 The Malta Chamber

More information

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution) Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution) This document should not be treated as a comprehensive guideline; it serves as a

More information

Good Practice Guidance on Covert Administration of Medication

Good Practice Guidance on Covert Administration of Medication Good Practice Guidance on Covert Administration of Medication This good practice guidance is intended to be used as a framework for care home managers and domiciliary care providers in drawing up their

More information

Challenges on commodity management at Facility Level: Experience from Baylor Center of Excellence, Mbeya

Challenges on commodity management at Facility Level: Experience from Baylor Center of Excellence, Mbeya Challenges on commodity management at Facility Level: Experience from Baylor Center of Excellence, Mbeya Nadiya A. Jiwa, B. Pharm., MSc. HPM Stakeholders meeting for HIV/AIDS commodities, Rukwa Overview

More information

Table of Contents. Understanding Your Medication Compounding Medications Medication Synchronization General Tips

Table of Contents. Understanding Your Medication Compounding Medications Medication Synchronization General Tips Table of Contents Understanding Your Medication Compounding Medications Medication Synchronization General Tips Note: most insurance carriers have a nurseline available to take questions. For more information,

More information

THE FACTS ABOUT PRESCRIPTION MEDICINE MISUSE

THE FACTS ABOUT PRESCRIPTION MEDICINE MISUSE JUNE This month, Health is Primary is focusing on safe use of prescription medicines. We are sharing the facts about the risks of medicine misuse and the importance of using medicines as prescribed along

More information

The pathway to better medicines for children

The pathway to better medicines for children The pathway to better medicines for children As the World Health Organization counts down to 2015 and the Millennium Development Goal to reduce under five-year-old mortality by two-thirds, we reflect on

More information

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State

More information

MOATT Card-Style Version: A single page MOATT (PDF) is also available at the MASCC website.

MOATT Card-Style Version: A single page MOATT (PDF) is also available at the MASCC website. MOATT V1.2 9/9/16 MOATT MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer This teaching tool has been prepared to assist healthcare providers in the assessment and education of patients

More information

IATT Optimal List of Paediatric ARV Formulations: Background and Update

IATT Optimal List of Paediatric ARV Formulations: Background and Update IATT Optimal List of Paediatric ARV Formulations: Background and Update Nandita Sugandhi Clinton Health Access Initiative, USA PADO/IATT Update for ARV Manufacturers October 19, 2015 Overview Rationale

More information

Stakeholder Comments and Responses for

Stakeholder Comments and Responses for Stakeholder Comments and Responses for Comprehensive Research Plan: Treatment of ADHD in Adults Consolidated Report April 29 th, 2015 30 Bond Street, Toronto ON, M5B 1W8 www.odprn.ca info@odprn.ca 2 OVERALL

More information

PRINCIPLES OF PEDIATRIC PHARMACOTHERAPY. Marianne Krupicka, Pharm.D. Oregon Health and Science University/ Doernbecher Children s Hospital

PRINCIPLES OF PEDIATRIC PHARMACOTHERAPY. Marianne Krupicka, Pharm.D. Oregon Health and Science University/ Doernbecher Children s Hospital PRINCIPLES OF PEDIATRIC PHARMACOTHERAPY Marianne Krupicka, Pharm.D. Oregon Health and Science University/ Doernbecher Children s Hospital References Pediatric Lexicomp Harriett Lane Respiratory Rate Newborn

More information

Update on the IATT Paediatric Formulary. WHO/UNAIDS Consultation with manufacturers March 2015, Geneva, Switzerland

Update on the IATT Paediatric Formulary. WHO/UNAIDS Consultation with manufacturers March 2015, Geneva, Switzerland Update on the IATT Paediatric Formulary WHO/UNAIDS Consultation with manufacturers March 2015, Geneva, Switzerland Summary The Challenge Rationale for Paediatric ARV Formulary Optimization 2015 Revised

More information

List of Optimal Paediatric Formulations. Marianne Gauval (CHAI) IAS-ILF Round table Geneva, Switzerland 26 November 2013

List of Optimal Paediatric Formulations. Marianne Gauval (CHAI) IAS-ILF Round table Geneva, Switzerland 26 November 2013 List of Optimal Paediatric Formulations Marianne Gauval (CHAI) IAS-ILF Round table Geneva, Switzerland 26 November 2013 1 History of development of treatment options for children Adult tablets Syrups and

More information

Travel Health: Selecting, Dosing, Storing & Administering Medications for Children

Travel Health: Selecting, Dosing, Storing & Administering Medications for Children Travel Health: Selecting, Dosing, Storing & Administering Medications for Children B. Seifert, Pharm.D., FCSHP Pediatric Clinical Pharmacist WRHA Regional Pharmacy Program April 2009 bseifert@hsc.mb.ca

More information

MODULE 1: BASIC DRUG KNOWLEDGE

MODULE 1: BASIC DRUG KNOWLEDGE MODULE 1: BASIC DRUG KNOWLEDGE 1.1 How Drugs Work A drug is a medicine or substance (but not food or water) which when ingested (or otherwise introduced into the body) alters the way the body works physically

More information

Gastrointestinal-Specific and General Physiology Issues in Pediatrics: Implications for Pediatric Formulation Development

Gastrointestinal-Specific and General Physiology Issues in Pediatrics: Implications for Pediatric Formulation Development Gastrointestinal-Specific and General Physiology Issues in Pediatrics: Implications for Pediatric Formulation Development Andrew E. Mulberg, MD, FAAP Division of Gastroenterology and Inborn Errors Products

More information

Malaria Initiative: Access

Malaria Initiative: Access Novartis Social Business Malaria Initiative: Access Improving affordability and availability of medicines Over the past decade, the Novartis Malaria Initiative has pioneered the pharmaceutical response

More information

CONSISTENT FDA APPROVED

CONSISTENT FDA APPROVED FLEXIBLE ACCURATE Exactly what ALL * patients need. CONSISTENT FDA APPROVED * Acute lymphoblastic leukemia. What is PURIXAN? PURIXAN (mercaptopurine) oral suspension is indicated for the treatment of patients

More information

Ensuring generic drug safety and efficacy via a combined effort of FDA, Academia, and the industry in a datadriven

Ensuring generic drug safety and efficacy via a combined effort of FDA, Academia, and the industry in a datadriven Ensuring generic drug safety and efficacy via a combined effort of FDA, Academia, and the industry in a datadriven era: part 2 Zhong Wang, Ph. D. Division of Quantative Methods and Modeling Offic of Research

More information

CONSIDERATION OF THE END USER AND THE LIMITATIONS DURING THE ORAL ADMINISTRATION DRUG DESIGN: CHALLENGE IN DIFFERENT AGE GROUPS

CONSIDERATION OF THE END USER AND THE LIMITATIONS DURING THE ORAL ADMINISTRATION DRUG DESIGN: CHALLENGE IN DIFFERENT AGE GROUPS CONSIDERATION OF THE END USER AND THE LIMITATIONS DURING THE ORAL ADMINISTRATION DRUG DESIGN: CHALLENGE IN DIFFERENT AGE GROUPS Adriana Quiroga Technical Manager Colorcon Latin South America 0 Summary

More information

Chapter 11 How to state your conditions clearly to the doctor

Chapter 11 How to state your conditions clearly to the doctor Chapter 11 How to state your conditions clearly to the doctor Chapter 11 How to state your conditions clearly to the doctor While seeing doctor, details of your statement should include the following:

More information

targets for HIV-positive children

targets for HIV-positive children Accessing antiretroviral therapy (ART) is a matter of life and death for HIV-infected children. Without ART, half of children born with HIV die by the age of two years, and 80 percent die by the age of

More information

Study of Consumer Preferences: Solid Oral Dosage Forms. Pharmaceutical n OTC n Dietary Supplement

Study of Consumer Preferences: Solid Oral Dosage Forms. Pharmaceutical n OTC n Dietary Supplement Pharmaceutical n OTC n Dietary Supplement Research by CAPSUGEL for OTC, Dietary Supplement and Pharmaceutical Marketers Study of Consumer Preferences: Solid Oral Dosage Forms Study of Consumer Preferences:

More information

PROSTRAKAN v SHIRE. Calcichew-D 3 Forte journal advertisement CASE AUTH/1825/4/06

PROSTRAKAN v SHIRE. Calcichew-D 3 Forte journal advertisement CASE AUTH/1825/4/06 CASE AUTH/1825/4/06 PROSTRAKAN v SHIRE Calcichew-D 3 Forte journal advertisement ProStrakan complained about a journal advertisement for Calcichew-D 3 Forte (calcium carbonate, colecalciferol) issued by

More information

How to inject op oxycontin

How to inject op oxycontin How to inject op oxycontin The Borg System is 100 % How to inject op oxycontin Injecting oxycontin is one of the primary methods of abusing this highly addictive prescription drug. Injecting oxycontin

More information

Some H2 Antihistaminics And Ppi-S Products Authorized In Albania And Their Availability For Pediatric Groups

Some H2 Antihistaminics And Ppi-S Products Authorized In Albania And Their Availability For Pediatric Groups Some H2 Antihistaminics And Ppi-S Products Authorized In Albania And Their Availability For Pediatric Groups Briseida Dosti, Msc. Ledjan Malaj, Prof. Medicine University of Tirana, Faculty of Pharmacy,

More information

Life-cycle approach to error prevention an overview

Life-cycle approach to error prevention an overview Life-cycle approach to error prevention an overview Kathryn Ord Unit Manager, Medicines and Healthcare products Regulatory Agency Information Day on Medication Errors 20 October 2016 London, UK Disclaimer

More information

Product Characteristics and Product Information Links between Quality and Clinical

Product Characteristics and Product Information Links between Quality and Clinical Product Characteristics and Product Information Links between Quality and Clinical Regine Lehnert 8th Annual Prequalification Assessment Training (Quality), Copenhagen, 16-18th May 2016 A Good Medicinal

More information

Exploring the role of stigma of rape and HIV on women s compliance to PEP after rape

Exploring the role of stigma of rape and HIV on women s compliance to PEP after rape Exploring the role of stigma of rape and HIV on women s compliance to PEP after rape Naeemah Abrahams Rachel Jewkes Gender & Health Research Unit Introduction Post Exposure Prophylaxis (PEP) to prevent

More information

Non-State Providers in Strengthening Health Systems Towards Universal Health Coverage PROJECT SUMMARIES

Non-State Providers in Strengthening Health Systems Towards Universal Health Coverage PROJECT SUMMARIES Bosnia and Herzegovina Engaging private healthcare providers in implementation of mandatory safety standards in the Republic of Srpska Budimka NOVAKOVIC Medical Faculty, University of Novi Sad Healthcare

More information

Recommended dosing for pediatric patients (6 months to 12 years of age) 1. Dose based on lopinavir component* 1.25 ml ml

Recommended dosing for pediatric patients (6 months to 12 years of age) 1. Dose based on lopinavir component* 1.25 ml ml Abbott Virology 100 Abbott Park Road Abbott Park, IL 60064 KALETRA 100/25 mg tablets NDC #0074-0522-60 Dear Healthcare Provider: Introducing a new strength of KALETRA (lopinavir/ritonavir): 100/25 mg tablets

More information

Oral Dose of TAMIFLU for Treatment (twice daily for 5 days) of Influenza in Pediatric Patients One Year of Age and Older by

Oral Dose of TAMIFLU for Treatment (twice daily for 5 days) of Influenza in Pediatric Patients One Year of Age and Older by Table 1 () Oral Dose of for Treatment (twice daily for 5 days) of Influenza in Pediatric Patients One Year of Age and Older by (lbs) Dose for 5 Days Amount of for Oral Suspension to Withdraw for Each Dose

More information

From the Clinic to Home: The Shift to Oral Oncolytic Therapy

From the Clinic to Home: The Shift to Oral Oncolytic Therapy From the Clinic to Home: The Shift to Oral Oncolytic Therapy Eric Vachon, BSN, RN Michigan State University, College of Nursing Disclosure I do not have anything to disclose. Objectives Oral oncolytics

More information

General Considerations for Age-Appropriate Formulations: FDA Clinical Perspective

General Considerations for Age-Appropriate Formulations: FDA Clinical Perspective General Considerations for Age-Appropriate Formulations: FDA Clinical Perspective Erica Radden, M.D. Medical Officer, Division of Pediatric and Maternal Health Office of New Drugs, FDA 1 Disclosure Statement

More information

Constructing antiretroviral regimens to overcome imperfect adherence

Constructing antiretroviral regimens to overcome imperfect adherence Constructing antiretroviral regimens to overcome imperfect adherence Amanda H. Corbett, PharmD, BCPS, FCCP, AAHIVE 7 th International Conference on HIV Treatment and Prevention Adherence June 4, 2012 Miami

More information

Experience of paediatric formulations in Marketing Authorisatrion Applications

Experience of paediatric formulations in Marketing Authorisatrion Applications Experience of paediatric formulations in Marketing Authorisatrion Applications Elisabeth RICCHI Senior Quality Assessor 1 Overview of the presentation Formulation Measuring device Reconstitution packaging

More information

A Call to Action Children The missing face of AIDS

A Call to Action Children The missing face of AIDS A Call to Action Children The missing face of AIDS OVERVIEW OF PRESENTATION Introduction : lessons learnt Availability ; implications of making paediatric formulations available Remaining challenges in

More information

Fang Liu University of Hertfordshire

Fang Liu University of Hertfordshire Fang Liu University of Hertfordshire Increasing attention from industry and academia in developing formulations for children since 2007 Raising recognition of the need of older patients There are similarities

More information

Starting with Tivicay

Starting with Tivicay Starting with Tivicay (dolutegravir) Read the package leaflet thoroughly before you use Tivicay. PATIENT INFORMATION Introduction You have been given this brochure because you will be using Tivicay and

More information

Not for Print Use. Not for Print Use. Rx for Safe Driving

Not for Print Use. Not for Print Use. Rx for Safe Driving For information on AAA s Safe Driving for Mature Operators Driver Improvement Program, contact your local AAA club. Rx for Safe Driving AAA s Mature Drivers series: Meeting the Challenge Buying a Vehicle

More information

POLICY Brief October 2017

POLICY Brief October 2017 Analysis of Efficiency Gains for Antiretroviral Therapy at the Facility Level using Multi-Month Scripting and a Differentiated Laboratory Management Algorithm in Tanzania POLICY Brief October 217 Authors:

More information

COPYRIGHTED MATERIAL. Introduction

COPYRIGHTED MATERIAL. Introduction 1 Introduction Pharmacology is the science of drugs and their effects on biological systems. A drug can be defined as a chemical that can cause a change in a biological system; the important biological

More information

TEVA 3927 Teva Teva TEVA 3927 TEVA 3927

TEVA 3927 Teva Teva TEVA 3927 TEVA 3927 Teva 3927 dosage about the reported side effects, related medications will. Save money on your Imprint Code: TEVA/3927. Jul 23, 2015. Your doctor may adjust your dose of diazepam if you are a poor. Color:

More information

Pediatric Compounding. Erika Fallon, PharmD/RPh

Pediatric Compounding. Erika Fallon, PharmD/RPh Pediatric Compounding Erika Fallon, PharmD/RPh Disclosure I, Erika Fallon, declare no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in

More information

Practical examples of PDCO advice on development programme; presentation of various case studies

Practical examples of PDCO advice on development programme; presentation of various case studies Safeguarding public health Practical examples of PDCO advice on development programme; presentation of various case studies Matthew Thatcher Clinical Assessor at MHRA UK Paediatric Committee delegate A

More information

Infection Control in Tanzania

Infection Control in Tanzania Infection Control in Tanzania Dr. Peter C. Mgosha (MPH,) MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS COTROL PROGRAMME P.O.BOX 11857 DAR Es SALAAM TANZANIA Out line Presentation Tanzania profile

More information

IMPROVING HIV HEALTH OUTCOMES FROM A PERSON-CENTERED APPROACH

IMPROVING HIV HEALTH OUTCOMES FROM A PERSON-CENTERED APPROACH IMPROVING HIV HEALTH OUTCOMES FROM A PERSON-CENTERED APPROACH T R A N S F O R M I N G C A R E C O N F E R E N C E, C O LU M B U S, O H O C T O B E R 1 9, 2 0 1 7 Kelly Wesp, PhD Bonney Harnish, PhD, RN,

More information

Factors influencing smoking among secondary school pupils in Ilala Municipality Dar es Salaam March 2007 By: Sadru Green (B.Sc.

Factors influencing smoking among secondary school pupils in Ilala Municipality Dar es Salaam March 2007 By: Sadru Green (B.Sc. tamsa Volume 15.qxd:Layout 1 6/9/08 3:51 PM Page 14 Factors influencing smoking among secondary school pupils in Ilala Municipality Dar es Salaam March 2007 By: Sadru Green (B.Sc. EHS3 2006/2007) ABSTRACT

More information

Impact of POC EID on infant case finding and treatment initiation. Durban, South Africa June

Impact of POC EID on infant case finding and treatment initiation. Durban, South Africa June Impact of POC EID on infant case finding and treatment initiation Durban, South Africa June 13 2017 Access to timely HIV diagnosis is limited for HIV-exposed infants, with high loss to follow-up rates

More information

Factsheet: Treatments for hepatitis C Direct Acting Antivirals (DAAs)

Factsheet: Treatments for hepatitis C Direct Acting Antivirals (DAAs) Factsheet: Treatments for hepatitis C Direct Acting Antivirals (DAAs) For more information about anything in this factsheet, phone the Hepatitis Infoline on 1800 703 003 or go to www.hepvic.org.au The

More information

Postoperative pain Home Sweet Home

Postoperative pain Home Sweet Home Postoperative pain Home Sweet Home Joint Annual Meeting 2016 BAPA, BELAPS & BePPa 23rd of April 2016 Muriel De Vel, Pijnverpleegkundige Pediatrie ZNA Sara Debulpaep, Kinderarts Kinderafdeling UZGent Postoperative

More information

Medicines Q&As Q&A What are the therapeutic options for patients unable to take solid oral dosage forms?

Medicines Q&As Q&A What are the therapeutic options for patients unable to take solid oral dosage forms? Medicines Q&As Q&A 294.3 What are the therapeutic options for patients unable to take solid oral dosage forms? Prepared by UK Medicines Information (UKMi) pharmacists for NHS healthcare professionals Before

More information

VITAMINS & SUPPLEMENTS

VITAMINS & SUPPLEMENTS VITAMINS & SUPPLEMENTS 2018 TREND INSIGHT REPORT With a rapidly increasing interest in personal health and wellness, more and more American consumers are incorporating vitamins and supplements as part

More information

Global Pulse Oximetry Project

Global Pulse Oximetry Project 3.3 Introduction of new health technologies: lessons learned Over the past twenty years there have been a number of comprehensive public health projects which illustrate important lessons regarding the

More information

In Australia, brand substitution of

In Australia, brand substitution of Pharmaceutical brand substitution in Australia are there multiple switches per prescription? Abstract Background: In Australia, brand substitution by pharmacists has been possible since 1994. There is

More information

Building Credibility In Health. Roger PHILLIPS

Building Credibility In Health. Roger PHILLIPS Building Credibility In Health Roger PHILLIPS Danone UK: Building Credibility In Health Health credibility is central to all divisions Dairy Waters Successful examples from each division in the UK Medical

More information

The Science of Palatability

The Science of Palatability The Science of Palatability www.palatech.com CANINE EQUINE Pala-Tech Laboratories, Inc. was founded in 1999 on the principle of palatable technology. This technology uses proprietary flavor bases for each

More information

TRANSPARENCY COMMITTEE OPINION. 19 July 2006

TRANSPARENCY COMMITTEE OPINION. 19 July 2006 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 19 July 2006 Keppra 250 mg, film-coated tablets Box of 60 tablets (CIP code: 356 013-6) Keppra 500 mg, film-coated

More information

E11(R1) Addendum to E11: Clinical Investigation of Medicinal Products in the Pediatric Population Step4

E11(R1) Addendum to E11: Clinical Investigation of Medicinal Products in the Pediatric Population Step4 E11(R1) Addendum to E11: Clinical Investigation of Medicinal Products in the Step4 October 2017 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 Legal

More information

Expanding Access to Injectable Contraception Geneva, June 2009

Expanding Access to Injectable Contraception Geneva, June 2009 Bangladesh Experience in Expanding the Delivery of Injectable Contraception A brief overview Presentation at Expanding Access to Injectable Contraception Geneva, 15-17 June 2009 Dr S. Thapa Reproductive

More information

The Science of Palatability

The Science of Palatability The Science of Palatability Pala-Tech Laboratories, Inc. was founded in 1999 on the principle of palatable technology. This technology uses proprietary flavor bases for each species, which are incorporated

More information

Frequently Asked Questions on Zinc and Suggested Responses

Frequently Asked Questions on Zinc and Suggested Responses Last edited: September 27, 2012 Zinc Treatment of Childhood Diarrhea Frequently Asked Questions Diarrhoea still remains a leading cause of morbidity and mortality in developing countries. Every year more

More information

PEDIATRIC. DEVELOPING PEDIATRIC STUDIES: Part 1: Patient Population Considerations STUDIES

PEDIATRIC. DEVELOPING PEDIATRIC STUDIES: Part 1: Patient Population Considerations STUDIES Abstract For many years, children have been put at an unnecessary risk through everyday medicines that had not been adequately researched in a pediatric population. The lack of safety, efficacy, evidence-based

More information

Documents Regarding Drug Abuse Assessments

Documents Regarding Drug Abuse Assessments Overview of the FDA Guidance Documents Regarding Drug Abuse Assessments ABUSE DETERRENT FORMULATION SCIENCE MEETING DISCUSSION OF THE FDA DRAFT GUIDANCE FOR INDUSTRY: ABUSE DETERRENT OPIOIDS EVALUATION

More information

Formulation factors affecting acceptability of oral medicines in children

Formulation factors affecting acceptability of oral medicines in children 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Formulation factors affecting acceptability of oral medicines in children Fang Liu 1*, Sejal Ranmal 2, Hannah K. Batchelor 3, Mine Orlu-Gul 2, Terry B. Ernest

More information

A Layperson s Guide to Pediatric Formulation Development

A Layperson s Guide to Pediatric Formulation Development A Layperson s Guide to Pediatric Formulation Development Karen C. Thompson PhD Senior Principal Scientist Preclinical Development Merck Research Laboratory West Point, Pennsylvania Martin J. Gartland PhD

More information

Uptake of and Retention on HIV Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Kenya

Uptake of and Retention on HIV Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Kenya Uptake of and Retention on HIV Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Kenya LINA DIGOLO, C OCHIENG, A NGUNJIRI, M KIRAGU, J KYONGO, L OTISO, W MUKOMA 8 T H I N T E R

More information

Areca nut epidemic among school children in Mumbai, India. Nishi Arora

Areca nut epidemic among school children in Mumbai, India. Nishi Arora Areca nut epidemic among school children in Mumbai, India Nishi Arora Context Oral cancer accounts for over 30% of cancers in India ranking first among all cancer cases in males, and is the third most

More information

Unrecorded Alcohol in Vietnam

Unrecorded Alcohol in Vietnam Unrecorded Alcohol in Vietnam Results of a Population Survey February 2018 Over the past decade, there has been a growing effort to measure and describe alcohol consumption and prevailing drinking patterns

More information

TABLE OF CONTENTS. Elizabeth Glaser Pediatric AIDS Foundation A Winnable Battle Report 2

TABLE OF CONTENTS. Elizabeth Glaser Pediatric AIDS Foundation  A Winnable Battle Report 2 TABLE OF CONTENTS List of Acronyms... 3 1.0 Background... 4 2.0 EGPAF Rapid Syphilis Testing Program Overview... 5 2.1. Introduction of RST in the four SMGL districts... 6 2.2 National-level Technical

More information

JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN

JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN WHO, UNAIDS and UNICEF, guided by recent evidence, have agreed to modify as an interim

More information

Integrated Community Case Management (iccm) and the role of pneumonia diagnostic tools

Integrated Community Case Management (iccm) and the role of pneumonia diagnostic tools Integrated Community Case Management (iccm) and the role of pneumonia diagnostic tools Theresa Diaz MD MPH Senior Health Advisor Health Section UNICEF, NY (on behalf of Mark Young) Strong need for community-based

More information

Assessing Medication Adherence

Assessing Medication Adherence Assessing Medication Adherence Dr. Lauren Hanna and Dr. Delbert Robinson Northwell Health National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental

More information

PROVIDERS VIEWS ON PREP FOR ADOLESCENT GIRLS AND YOUNG WOMEN IN TANZANIA

PROVIDERS VIEWS ON PREP FOR ADOLESCENT GIRLS AND YOUNG WOMEN IN TANZANIA results brief 2 PROVIDERS VIEWS ON PREP FOR ADOLESCENT GIRLS AND YOUNG WOMEN IN TANZANIA FINDINGS FROM IMPLEMENTATION SCIENCE RESEARCH JUNE 2017 girls and young women (AGYW) continue to have high rates

More information

REGION 1 EMERGENCY MEDICAL SERVICES STANDING MEDICAL ORDERS EMT Basic, EMT Intermediate, EMT Paramedic. SMO: Pediatric Assessment Guidelines

REGION 1 EMERGENCY MEDICAL SERVICES STANDING MEDICAL ORDERS EMT Basic, EMT Intermediate, EMT Paramedic. SMO: Pediatric Assessment Guidelines REGION 1 EMERGENCY MEDICAL SERVICES STANDING MEDICAL ORDERS EMT Basic, EMT Intermediate, EMT Paramedic SMO: Pediatric Assessment Guidelines Overview: Pediatric patients account for about 10% or less of

More information

Smiles for Ohio Fluoride Varnish Program

Smiles for Ohio Fluoride Varnish Program Fluoride Supplementation Dietary fluoride supplements are available by prescription only. Physicians and dentists may prescribe dietary fluoride supplements for infants and children who are not served

More information

Antiretroviral Pharmacovigilance Training Course. Dar es Salaam, United Republic of Tanzania

Antiretroviral Pharmacovigilance Training Course. Dar es Salaam, United Republic of Tanzania Antiretroviral Pharmacovigilance Training Course Dar es Salaam, United Republic of Tanzania 23 rd 28 th November 2009 SAFETY MONITORING OF ARVs IN GHANA NATIONAL AIDS/STI CONTROL PROGRAMME FOOD AND DRUGS

More information

Kaletra (HIV) Forecast and Market Analysis to GDHC1051DFR/ Published January 2013

Kaletra (HIV) Forecast and Market Analysis to GDHC1051DFR/ Published January 2013 Kaletra (HIV) Forecast and Market Analysis to 2022 GDHC1051DFR/ Published January 2013 Executive Summary Kaletra Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US - Kaletra 5EU

More information

MEDICATION PORTFOLIO Medication Generic Brand Pharmkinetics. Other nursing implications. Dose / route. Pharmdynamics. Side effects

MEDICATION PORTFOLIO Medication Generic Brand Pharmkinetics. Other nursing implications. Dose / route. Pharmdynamics. Side effects MEDICATION PORTFOLIO Medication Generic Brand Pharmkinetics Pharmdynamics Dose / route Side effects Other nursing implications History of Pharmacology Pharmacology- the study of what happens to the human

More information

Taking Health & Nutrition to the NEXT Level

Taking Health & Nutrition to the NEXT Level Taking Health & Nutrition to the NEXT Level 1. Who We are 2. Softigel by Procaps 3. Strategically Located sites Take 10 minutes to get to know us better 4. Our Quality Certifications 5. Product Development

More information

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care 203 - Monday, April 16, 2018 Today s Presenters Ben Purser Former F.B.I. Special Agent Donna Thiel ProviderTrust Chief

More information

Jefferies Healthcare Conference June 6, 2018

Jefferies Healthcare Conference June 6, 2018 Jefferies Healthcare Conference June 6, 2018 Forward-Looking Statements Some of the statements included in this presentation, particularly those regarding the commercialization and ongoing clinical development

More information

The Sensory Processing Measure (SPM, SPM-P, and SPM-2)

The Sensory Processing Measure (SPM, SPM-P, and SPM-2) The Sensory Processing Measure (SPM, SPM-P, and SPM-2) Moving Toward Assessment Across the Lifespan L. Diane Parham, PhD, OTR/L, FAOTA Professor, Occupational Therapy Graduate Program DiParham@salud.unm.edu

More information

Wellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion)

Wellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion) Wellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion) Generic name: Bupropion Available strengths: 75 mg, 100 mg immediate-release tablets; 100 mg, 150 mg, 200 mg sustained-release tablets (Wellbutrin-SR);

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary tract infection: diagnosis, treatment and long-term management of urinary tract infection in children 1.1 Short title

More information

Paediatric HIV Resistance. Mohern Archary Paediatric Infectious Diseases Unit King Edward VIII Hospital / University of KwaZulu Natal

Paediatric HIV Resistance. Mohern Archary Paediatric Infectious Diseases Unit King Edward VIII Hospital / University of KwaZulu Natal Paediatric HIV Resistance Mohern Archary Paediatric Infectious Diseases Unit King Edward VIII Hospital / University of KwaZulu Natal Preliminary evaluation of referrals for Antiretroviral Therapy (ART)

More information

Esophageal Cancer in Tanzania

Esophageal Cancer in Tanzania Esophageal Cancer in Tanzania Katherine Van Loon, MD, MPH Assistant Clinical Professor Director of Global Oncology Program Helen Diller Family Comprehensive Cancer Center University of California, San

More information

Product Makes Perfect

Product Makes Perfect Product Makes Perfect Human-Centered Design for HIV Self-Testing and Prevention USAID MINI-U // 03.04.16 // 2-3PM Roadmap What is Human-Center Design (HCD)? How can HCD be applied to HIV and AIDS? - Microbicides

More information

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products Stability of an Extemporaneously Compounded Humco s Oral Products Pradeep Gautam, MS* 1 1 Address correspondence to Pradeep Gautam, HUMCO Research and Development Laboratory, 201 W. 5 th St. Suite 1250,

More information

A survey on antiemetics prescribed for children in some selected districts of Sri Lanka

A survey on antiemetics prescribed for children in some selected districts of Sri Lanka Original Articles A survey on antiemetics prescribed for children in some selected districts of Sri Lanka S Sri Ranganathan 1, K Mayurathan 2, R Fernandopulle 3 Sri Lanka Journal of Child Health, 2010;

More information

Talking about medicines to patients: the good the bad and the ugly

Talking about medicines to patients: the good the bad and the ugly School of Healthcare FACULTY OF MEDICINE AND HEALTH Talking about medicines to patients: the good the bad and the ugly Improving the way we inform patients MUSN Meeting London, May 2016 DK Theo Raynor

More information

Application for Inclusion of Lopinavir /Ritonavir Oral Granules (LPV/r) Formulation on WHO Model List of Essential Medicines for Children

Application for Inclusion of Lopinavir /Ritonavir Oral Granules (LPV/r) Formulation on WHO Model List of Essential Medicines for Children Application for Inclusion of Lopinavir /Ritonavir Oral Granules (LPV/r) Formulation on WHO Model List of Essential Medicines for Children Table of Contents 1. Summary statement of proposal for inclusion...

More information

Syncytial Virus. Surveillance: A. Respiratory (RSV) New Initiative for NM

Syncytial Virus. Surveillance: A. Respiratory (RSV) New Initiative for NM Respiratory Syncytial Virus (RSV) Surveillance: A New Initiative for NM Sarah Shrum, MPH EIP Surveillance Officer, NMDOH EIP Day Conference September 23 rd, 2016 Objectives 1. Describe basic virology,

More information

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy Dr. Philipp Hebestreit, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 12 July 2011 Original:

More information

The Global Accelerator for Paediatric Formulations (GAP-f) Ensuring children have accelerated access to optimal drug formulations

The Global Accelerator for Paediatric Formulations (GAP-f) Ensuring children have accelerated access to optimal drug formulations Slide 1 The Global Accelerator for Paediatric Formulations (GAP-f) Ensuring children have accelerated access to optimal drug formulations Sébastien Morin (International AIDS Society, Switzerland) 9 th

More information

Telephone Cognitive Behavioral Therapy for Rural Latinos: A Randomized Pilot Study

Telephone Cognitive Behavioral Therapy for Rural Latinos: A Randomized Pilot Study Telephone Cognitive Behavioral Therapy for Rural Latinos: A Randomized Pilot Study Gino Aisenberg, PhD UW School of Social Work Megan Dwight Johnson, MD MPH RAND Corporation Daniela Golinelli,, PhD RAND

More information